Techpool Bio-Pharma
CompanyChina
Techpool Bio-Pharma develops one asset, in phase 1 (ulinastatin in ulinastatin). Mostly protein or enzyme; based in China.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 2
- Signals
Pipeline
1Inhibits serine proteases, including trypsin and neutrophil elastase, limiting inflammation and tissue injury.
Phase 1, Protein or enzyme, ulinastatin
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals4